Can-Fite BioPharma (CANF) Liabilities and Shareholders Equity (2013 - 2026)
Can-Fite BioPharma (CANF) reported Liabilities and Shareholders Equity of $8.06 million for Q2 2026, up 4.3% from $7.72 million a year earlier.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends
At the end of FY2025, Can-Fite BioPharma posted Liabilities and Shareholders Equity of $9.51 million, up 4.3% from FY2024.
- Liabilities and Shareholders Equity has a five-year compound annual growth rate of 0.0% (FY2020 to FY2025).
- By year, Liabilities and Shareholders Equity came in at $9.12 million in FY2024 (-8.7%), $9.99 million in FY2023 (+7.6%), $9.28 million in FY2022 (-54.2%) and $20.25 million in FY2021 (+112.7%).
- Five-year quarterly Liabilities and Shareholders Equity spans a low of $5.92 million in Q2 2024 and a high of $20.25 million in Q4 2021.
- Year over year, Liabilities and Shareholders Equity gained in three of the last four quarters, with growth averaging 7.6%.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was Q4 2021 (growth of 112.7%); the low point was Q4 2022 (a decline of 54.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Can-Fite BioPharma | 1.82 Mn | -17.88 Mn | - | 8.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.06 Mn |
| Dec 31, 2025 | 9.51 Mn |
| Jun 30, 2025 | 7.72 Mn |
| Dec 31, 2024 | 9.12 Mn |
| Jun 30, 2024 | 5.92 Mn |
| Dec 31, 2023 | 9.99 Mn |
| Sep 30, 2023 | 9.17 Mn |
| Jun 30, 2023 | 11.03 Mn |
| Mar 31, 2023 | 13.49 Mn |
| Dec 31, 2022 | 9.28 Mn |
| Sep 30, 2022 | 12.71 Mn |
| Jun 30, 2022 | 14.75 Mn |
| Mar 31, 2022 | 17.85 Mn |
| Dec 31, 2021 | 20.25 Mn |
| Sep 30, 2021 | 14.64 Mn |
| Jun 30, 2021 | 9.68 Mn |
| Mar 31, 2021 | 12.74 Mn |
| Dec 31, 2020 | 9.52 Mn |
| Sep 30, 2020 | 13.33 Mn |
| Jun 30, 2020 | 12.80 Mn |
API Access
Can-Fite BioPharma Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();